Page last updated: 2024-08-17

quinoxalines and Dermatoses

quinoxalines has been researched along with Dermatoses in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baselga, J; Bedell, C; Braña, I; Edelman, G; Egile, C; Kwak, EL; Laird, AD; Nguyen, LT; Pandya, SS; Rodon, J; Scheffold, C; Shapiro, GI; Xu, Y	1
Fraser, K	1
Dupont, P; Gillet, C; Guerin, M; Guillaumin, C; Kalamarides, S; Larinier, E; Meignan, C; Moreau, A; Perriot, J	1

Trials

1 trial(s) available for quinoxalines and Dermatoses

Article	Year
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-01, Volume: 20, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Signal Transduction; Skin Diseases; Sulfonamides; Treatment Outcome	2014

Article

Year

Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-01, Volume: 20, Issue:1

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Signal Transduction; Skin Diseases; Sulfonamides; Treatment Outcome

2014

Other Studies

2 other study(ies) available for quinoxalines and Dermatoses

Article	Year
72nd annual meeting of the American Academy of Dermatology. American journal of clinical dermatology, 2014, Volume: 15, Issue:2 Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States	2014
[Tolerability profile of varenicline in current medical practice]. Presse medicale (Paris, France : 1983), 2010, Volume: 39, Issue:1 Topics: Adult; Benzazepines; Female; France; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Metabolic Diseases; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Skin Diseases; Smoking; Varenicline	2010

Article

Year

72nd annual meeting of the American Academy of Dermatology.

American journal of clinical dermatology, 2014, Volume: 15, Issue:2

Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States

2014

[Tolerability profile of varenicline in current medical practice].

Presse medicale (Paris, France : 1983), 2010, Volume: 39, Issue:1

Topics: Adult; Benzazepines; Female; France; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Metabolic Diseases; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Skin Diseases; Smoking; Varenicline

2010